446 related articles for article (PubMed ID: 31633228)
41. Does preoperative administration of gabapentin/pregabalin improve postoperative nasal surgery pain?
Park IJ; Kim G; Ko G; Lee YJ; Hwang SH
Laryngoscope; 2016 Oct; 126(10):2232-41. PubMed ID: 26925956
[TBL] [Abstract][Full Text] [Related]
42. Evaluation of Gabapentin and Pregabalin Use in Hospitalized Patients With Decreased Kidney Function.
Knowles GM; LaFleur GE; Churchwell MD
J Pharm Technol; 2024 Feb; 40(1):30-36. PubMed ID: 38318261
[No Abstract] [Full Text] [Related]
43. Identification of patients with painful diabetic peripheral neuropathy who have a favorable cost profile with pregabalin treatment.
Udall M; Mardekian J; Cabrera J
Pain Pract; 2013 Jul; 13(6):476-84. PubMed ID: 23150918
[TBL] [Abstract][Full Text] [Related]
44. Do surgical patients benefit from perioperative gabapentin/pregabalin? A systematic review of efficacy and safety.
Tiippana EM; Hamunen K; Kontinen VK; Kalso E
Anesth Analg; 2007 Jun; 104(6):1545-56, table of contents. PubMed ID: 17513656
[TBL] [Abstract][Full Text] [Related]
45. Use of anticonvulsants and antidepressants for treatment of complex regional pain syndrome: a literature review.
Javed S; Abdi S
Pain Manag; 2021 Mar; 11(2):189-199. PubMed ID: 33183126
[TBL] [Abstract][Full Text] [Related]
46. Duloxetine Compared with Pregabalin for Diabetic Peripheral Neuropathic Pain Management in Patients with Suboptimal Pain Response to Gabapentin and Treated with or without Antidepressants: A Post Hoc Analysis.
Tanenberg RJ; Clemow DB; Giaconia JM; Risser RC
Pain Pract; 2014 Sep; 14(7):640-8. PubMed ID: 24152185
[TBL] [Abstract][Full Text] [Related]
47. Gabapentinoid use in French most precarious populations: Insight from Lyon Permanent Access to Healthcare (PASS) units, 2016-1Q2021.
Chappuy M; Nourredine M; Clerc B; Fahmi M; Misslin P; Berthier M; Laloi L; Rolland B
Fundam Clin Pharmacol; 2022 Apr; 36(2):448-452. PubMed ID: 34498306
[TBL] [Abstract][Full Text] [Related]
48. Gabapentin and pregabalin for the acute post-operative pain management. A systematic-narrative review of the recent clinical evidences.
Dauri M; Faria S; Gatti A; Celidonio L; Carpenedo R; Sabato AF
Curr Drug Targets; 2009 Aug; 10(8):716-33. PubMed ID: 19702520
[TBL] [Abstract][Full Text] [Related]
49. Gabapentinoid Dosing and Associated Toxicities in Patients With or Without Concomitant Opioids During Hospitalization.
Tu TG; Sadeghi S; Atayee R; Lee K
Am J Hosp Palliat Care; 2022 May; 39(5):530-534. PubMed ID: 34409886
[TBL] [Abstract][Full Text] [Related]
50. Association of Gabapentin or Pregabalin Use and Incidence of Acute Angle-closure Glaucoma.
Browne MJ; Zakrzewski H; Carleton B; Etminan M; Mikelberg FS
J Glaucoma; 2019 Sep; 28(9):777-779. PubMed ID: 31335554
[TBL] [Abstract][Full Text] [Related]
51. The efficacy of morphine, pregabalin, gabapentin, and duloxetine on mechanical allodynia is different from that on neuroma pain in the rat neuropathic pain model.
Miyazaki R; Yamamoto T
Anesth Analg; 2012 Jul; 115(1):182-8. PubMed ID: 22415534
[TBL] [Abstract][Full Text] [Related]
52. Donepezil, an Acetylcholinesterase Inhibitor, Can Attenuate Gabapentinoid-Induced Somnolence in Patients with Neuropathic Pain: A Retrospective Chart Review.
Kogure T; Sumitani M; Ikegami K; Abe H; Hozumi J; Inoue R; Kawahara K; Yamada Y
J Pain Palliat Care Pharmacother; 2017 Mar; 31(1):4-9. PubMed ID: 28287355
[TBL] [Abstract][Full Text] [Related]
53. Characteristics of fatal gabapentinoid-related poisoning in Australia, 2000-2020.
Darke S; Duflou J; Peacock A; Farrell M; Lappin J
Clin Toxicol (Phila); 2022 Mar; 60(3):304-310. PubMed ID: 34402696
[TBL] [Abstract][Full Text] [Related]
54. Trends in new prescription of gabapentinoids and of coprescription with opioids in the 4 nations of the UK, 1993-2017.
Rahman A; Kane J; Montastruc F; Renoux C
Br J Clin Pharmacol; 2021 Aug; 87(8):3349-3353. PubMed ID: 33393673
[TBL] [Abstract][Full Text] [Related]
55. Ultra-Low Doses of Naltrexone Enhance the Antiallodynic Effect of Pregabalin or Gabapentin in Neuropathic Rats.
Pineda-Farias JB; Caram-Salas NL; Salinas-Abarca AB; Ocampo J; Granados-Soto V
Drug Dev Res; 2017 Dec; 78(8):371-380. PubMed ID: 28868795
[TBL] [Abstract][Full Text] [Related]
56. [Off-label use of gabapentinoid drugs: is it necessary a deprescription strategy?].
Echeverría Gorriti A; Alzueta Istúriz N; García González P; Fernández González J; Sanz Álvarez L; Garjón Parra J
Gac Sanit; 2023; 37():102283. PubMed ID: 36565565
[TBL] [Abstract][Full Text] [Related]
57. Gabapentin and pregabalin: do the benefits outweigh the harms?
Morrison EE; Sandilands EA; Webb DJ
J R Coll Physicians Edinb; 2017 Dec; 47(4):310-313. PubMed ID: 29537399
[TBL] [Abstract][Full Text] [Related]
58. Experience from therapeutic drug monitoring and gender aspects of gabapentin and pregabalin in clinical practice.
Johannessen Landmark C; Beiske G; Baftiu A; Burns ML; Johannessen SI
Seizure; 2015 May; 28():88-91. PubMed ID: 25758302
[TBL] [Abstract][Full Text] [Related]
59. Assessment of the Safety Signal for the Abuse Potential of Pregabalin and Gabapentin Using the FAERS Database and Big Data Search Analytics.
Papazisis G; Spachos D; Siafis S; Pandria N; Deligianni E; Tsakiridis I; Goulas A
Front Psychiatry; 2021; 12():640264. PubMed ID: 34093263
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
